STOCK TITAN

Video: UK Festival of Genomics & Biodata Inspires and Connects Genomics Leaders

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Illumina participated as lead sponsor at the Festival of Genomics & Biodata 2023 in London, gathering over 4,000 experts from health care, academia, and technology. Key discussions included advancements in genomics and its impact on patient care. Notably, Illumina showcased its NovaSeq X series, highlighted as the most sustainable and powerful sequencer to date. The event emphasized the importance of genomics in transforming health care, with contributions from leaders from NHS England and Genomics England. Illumina's ongoing collaboration with the UK government aims to enhance the country's position in global genomics research.

Positive
  • Illumina served as the lead sponsor of a prominent genomics event, enhancing its industry visibility.
  • Showcased the NovaSeq X series, expected to drive future growth in the genomics market.
  • Engaged with top leaders in genomics, strengthening partnerships and collaborations.
Negative
  • None.

NORTHAMPTON, MA / ACCESSWIRE / January 31, 2023 / Illumina

Originally published on Illumina News Center

The Festival of Genomics & Biodata 2023, held in London in January, is the largest event in the UK's genomics events calendar. More than 4000 delegates from health care, academia, technology, and pharma came together to network and share the latest findings and cutting-edge advances. Discussions and keynote sessions from Illumina leaders and experts from NHS England, Genomics England, and UK Biobank, among others, focused on how genomics can make a difference in patients' lives and transform the future of health care.

As lead sponsor of the event, Illumina conducted two keynote sessions. On the first day, Illumina Senior Director of Scientific Research Clare Kingsley led a panel discussion titled Welcome to the Genome Era. She engaged with experts from the University of Cambridge, Genomics England, and the All Wales Medical Genomics Service on the latest genomics applications and trends. On day two, Illumina's Richard Capper and Jason Betley discussed the company's latest technological innovations and how they can be applied in genomics research, from precision oncology to environmental DNA.

Illumina presented its newest technology at the festival, including the NovaSeq X series-the company's most sustainable and most powerful sequencer to date-which will help meet the ever-increasing demand for sequencing and analysis and push the boundaries of precision medicine.

Illumina has supported the Festival of Genomics since the very beginning-eight years ago. We're proud of our links with the UK government and the NHS, as the UK embarks on a series of major research projects in 2023 that will help cement its position as a global leader in genomics.

Susan Tousi, Chief Commercial Officer of Illumina

Learn more about how Illumina is expanding access to genomics, click here.

View additional multimedia and more ESG storytelling from Illumina on 3blmedia.com.

Contact Info:
Spokesperson: Illumina
Website: https://www.3blmedia.com/profiles/illumina
Email: info@3blmedia.com

SOURCE: Illumina



View source version on accesswire.com:
https://www.accesswire.com/737516/Video-UK-Festival-of-Genomics-Biodata-Inspires-and-Connects-Genomics-Leaders

FAQ

What was Illumina's role at the Festival of Genomics 2023?

Illumina served as the lead sponsor and conducted keynote sessions, focusing on the latest advancements in genomics.

What technology did Illumina showcase at the Festival of Genomics?

Illumina presented its NovaSeq X series, noted as the most sustainable and powerful sequencer to date.

How does Illumina's participation impact its position in the genomics industry?

Illumina's participation as a lead sponsor reinforces its leadership and collaboration in advancing genomics research.

When and where was the Festival of Genomics held?

The Festival of Genomics took place in January 2023 in London.

Illumina Inc

NASDAQ:ILMN

ILMN Rankings

ILMN Latest News

ILMN Stock Data

21.99B
158.14M
0.27%
95.23%
4.26%
Diagnostics & Research
Laboratory Analytical Instruments
Link
United States of America
SAN DIEGO